Growth hormone-induced insulin resistance is associated with increased intramyocellular triglyceride content but unaltered VLDL-triglyceride kinetics. (Q40265810)

From Wikidata

Jump to navigation Jump to search

scientific article published on 28 November 2006

Language	Label	Description	Also known as
English	Growth hormone-induced insulin resistance is associated with increased intramyocellular triglyceride content but unaltered VLDL-triglyceride kinetics.	scientific article published on 28 November 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17132823%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Growth hormone-induced insulin resistance is associated with increased intramyocellular triglyceride content but unaltered VLDL-triglyceride kinetics (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17132823%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

insulin resistance

1 reference

based on heuristic

inferred from title

Jens Otto Lunde Jørgensen

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17132823%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Lars Christian Gormsen

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17132823%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Lars Christian Gormsen

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17132823%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Jens Sandahl Christiansen

5

object named as

Jens S Christiansen

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17132823%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

author name string

Morten B Krag

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17132823%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Zengkui Guo

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17132823%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Michael D Jensen

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17132823%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Søren Nielsen

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17132823%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

publication date

28 November 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17132823%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

American Journal of Physiology - Endocrinology and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17132823%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

292

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17132823%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17132823%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

E920-7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17132823%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Contributions of de novo synthesis of fatty acids to total VLDL-triglyceride secretion during prolonged hyperglycemia/hyperinsulinemia in normal man.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00374.2006

21 January 2018

Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans. European Group for the Study of Insulin Resistance (EGIR).

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00374.2006

21 January 2018

FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00374.2006

21 January 2018

Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00374.2006

21 January 2018

Glucose clamp technique: a method for quantifying insulin secretion and resistance

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00374.2006

21 January 2018

Growth hormone alters lipolysis and hormone-sensitive lipase activity in 3T3-F442A adipocytes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00374.2006

21 January 2018

Additive effects of cortisol and growth hormone on regional and systemic lipolysis in humans

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00374.2006

21 January 2018

Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00374.2006

21 January 2018

Calculation of substrate oxidation rates in vivo from gaseous exchange.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00374.2006

21 January 2018

Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00374.2006

21 January 2018

Measuring VLDL-triglyceride turnover in humans using ex vivo-prepared VLDL tracer.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00374.2006

21 January 2018

Energy expenditure, insulin, and VLDL-triglyceride production in humans.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00374.2006

21 January 2018

Triglyceride content in skeletal muscle: variability and the source

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00374.2006

21 January 2018

Splanchnic metabolism of free fatty acids and production of triglycerides of very low density lipoproteins in normotriglyceridemic and hypertriglyceridemic humans

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00374.2006

21 January 2018

Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00374.2006

21 January 2018

Evidence against a role for insulin-signaling proteins PI 3-kinase and Akt in insulin resistance in human skeletal muscle induced by short-term GH infusion

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00374.2006

21 January 2018

Acute exposure to GH during exercise stimulates the turnover of free fatty acids in GH-deficient men.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00374.2006

21 January 2018

Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00374.2006

21 January 2018

Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00374.2006

21 January 2018

Validation of a new method for determination of free fatty acid turnover

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00374.2006

21 January 2018

Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00374.2006

21 January 2018

The effect of long-term pharmacological antilipolysis on substrate metabolism in growth hormone (GH)-substituted GH-deficient adults

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00374.2006

21 January 2018

Effects of GH on urea, glucose and lipid metabolism, and insulin sensitivity during fasting in GH-deficient patients

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00374.2006

21 January 2018

The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00374.2006

21 January 2018

Regulation of lipoprotein lipase and hormone-sensitive lipase activity and gene expression in adipose and muscle tissue by growth hormone treatment during weight loss in obese patients

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00374.2006

21 January 2018

Effect of nicotinic acid administration on hepatic very low density lipoprotein-triglyceride production

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00374.2006

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40265810&oldid=2134154027"